Mackenzie Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7K | Buy |
17,499
+2,409
| +16% | +$2.99K | ﹤0.01% | 1675 |
|
|
2025
Q1 | $17.8K | Hold |
15,090
| – | – | ﹤0.01% | 1645 |
|
|
2024
Q4 | $27.6K | Hold |
15,090
| – | – | ﹤0.01% | 1678 |
|
|
2024
Q3 | $25.7K | Hold |
15,090
| – | – | ﹤0.01% | 1561 |
|
|
2024
Q2 | $20.7K | Hold |
15,090
| – | – | ﹤0.01% | 1518 |
|
|
2024
Q1 | $56.6K | Hold |
15,090
| – | – | ﹤0.01% | 1474 |
|
|
2023
Q4 | $148K | Hold |
15,090
| – | – | ﹤0.01% | 1371 |
|
|
2023
Q3 | $118K | Hold |
15,090
| – | – | ﹤0.01% | 1333 |
|
|
2023
Q2 | $195K | Hold |
15,090
| – | – | ﹤0.01% | 1342 |
|
|
2023
Q1 | $175K | Hold |
15,090
| – | – | ﹤0.01% | 1359 |
|
|
2022
Q4 | $123K | Hold |
15,090
| – | – | ﹤0.01% | 1303 |
|
|
2022
Q3 | $88K | Sell |
15,090
-265
| -2% | -$1.55K | ﹤0.01% | 1315 |
|
|
2022
Q2 | $68K | Buy |
15,355
+4,441
| +41% | +$19.7K | ﹤0.01% | 1369 |
|
|
2022
Q1 | $99K | Buy |
10,914
+283
| +3% | +$2.57K | ﹤0.01% | 1338 |
|
|
2021
Q4 | $218K | Sell |
10,631
-754
| -7% | -$15.5K | ﹤0.01% | 1301 |
|
|
2021
Q3 | $291K | Buy |
11,385
+4,710
| +71% | +$120K | ﹤0.01% | 1148 |
|
|
2021
Q2 | $233K | Buy |
+6,675
| New | +$233K | ﹤0.01% | 1123 |
|